Physician profile
Daniel Andersen
NPI 1841856515
$19,008.18
in general payments reported to CMS, 2019-2025
13 companies · $4,360 in 2025
The $4,360 reported for 2025 was more than what 81% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,821 · 2022: $8,169 · 2023: $285 · 2024: $1,373 · 2025: $4,360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,957 · Food and Beverage: $2,061.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,956.89 |
| Food and Beverage | $2,061.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $12,080.31 | 2021-2024 | |
| Medical Device Business Services, INC. | $2,234.83 | 2024-2025 | Na, Velys |
| Stryker Corporation | $1,305.85 | 2023-2025 | Mako, Alphavent, Variax |
| Kairos Surgical INC | $1,139.86 | 2024-2025 | |
| Acumed LLC | $915.20 | 2022 | |
| Arthrex, INC. | $462.45 | 2025 | |
| Depuy Synthes Sales INC. | $453.15 | 2024-2025 | Dynacord, Truespan Orthocord, Healix Knotless Peek |
| Osteoremedies, LLC | $172.50 | 2025 | Remedy Spacer, Biobrush, Osteoboost Select 5cc |
| Convatec INC. | $124.27 | 2023 | |
| Abbvie INC. | $47.56 | 2023 | Vuity |
| Pacira Pharmaceuticals Incorporated | $26.64 | 2024 | Exparel, Iovera |
| Smith+Nephew, INC. | $25.17 | 2022 | |
| Zimmer Biomet Holdings, INC. | $20.39 | 2025 | Identity, Comprehensive Shoulder System, Juggerknotless Soft Anchor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Andersen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.